Skip to content

Fluorescence Angiography in the Assessment of DIEP Flap Perfusion

Indocyanine Green Fluorescence Angiography in the Assessment of Deep Inferior Epigastric Perforator (DIEP) Flap Perfusion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02759796
Enrollment
60
Registered
2016-05-03
Start date
2015-11-30
Completion date
2017-04-30
Last updated
2017-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Fat Necrosis, Vascularization

Brief summary

It is a single-center, prospective, randomized and controlled study focused in microsurgical autologous breast reconstruction. It involves applying indocyanine green (ICG) angiography for the study of the vascularization of DIEP flaps. The aim of the study is to determine whether there are differences in complications and aesthetic results when ICG is used to discard the poorly vascularized areas of the flap. The study includes adult women undergoing unilateral DIEP flap breast reconstruction. The calculated sample size is 60 patients. There are two groups. In group 1, the investigators use the usual clinical criteria to discard the poorly vascularized areas of the flap. In group 2, the investigators use the ICG to shape the flap.

Interventions

PROCEDURETailoring the flap according to clinical assessment

After microvascular anastomosis is performed, the investigators clinically assess flap vascularization and the well vascularized tissue is marked by means of a dermographic pencil. Then the investigators administer 0,2mg/kg of ICG intravenously. The vascularization of the flap is also checked by means of the Photo Dynamic Eye (Pulsion Medical System) but finally the decision of discarding the poorly vascularized areas of the flap is made by clinical assessment.

PROCEDURETailoring the flap according to ICG Angiography assessment

After microvascular anastomosis is performed, the investigators administer 0,2mg/kg of ICG intravenously. Then the investigators check the vascularization of the flap by means of the Photo Dynamic Eye (Pulsion Medical System) and the poorly vascularized areas of the flap are discarded guided by ICG perfusion test.

Sponsors

Instituto de Investigación Hospital Universitario La Paz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Mastectomized adult female patient * Abdominal flap unilateral breast reconstruction indication * Alloplastic breast reconstruction sequelae * Enough amount of abdominal dermofat tissue to shape a breast with a primary closure of the donor site

Exclusion criteria

* DIEP flap bilateral breast reconstruction indication * Previous abdominoplasty surgery * Untreated psychiatric disease * Untreated infection * Indocyanine green or iodine hypersensitivity * Hyperthyroidism, thyroid adenoma or thyroid autonomy * Any concomitant disease or condition that, in the opinion of the investigator, can make the patient unsuitable to receive a microsurgical technique or to join the research.

Design outcomes

Primary

MeasureTime frame
Number of participants with fat necrosis as assessed by physical examinationSix months postoperatively
Number of participants with fat necrosis as assessed by ultrasonographySix months postoperatively

Secondary

MeasureTime frame
Number of participants with wound healing delay as assessed by physical examinationFrom two weeks postoperatively to two months postoperatively
Number of participants with reoperationFrom immediate postoperative moment to one year postoperatively
Flap perfusion index as assessed by IC-CALC software (Pulsion Medical System)Intraoperatively
Flap weight (grams)Intraoperatively
Number of participants with flap failure as assessed by physical examinationFrom intraoperative moment to one week postoperatively
Breast-Q questionnaire (preoperative reconstruction module) to measure patient preoperative statusA preoperative test in the last week before surgery
Breast-Q questionnaire (postoperative reconstruction module) to measure patient postoperative statusA postoperative test one year after surgery
ICG security (Number of participants with tachycardia, exanthema and anaphylactic shock as assessed by physical examination and intraoperative monitoring)Intraoperatively
Flap length (centimeters)Intraoperatively
Number of participants with wound infection as assessed by physical examinationFrom one day postoperatively to two weeks postoperatively

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026